Home Applications 213756 Application 213756
Type NDA
Sponsor ASTRAZENECA LP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 KOSELUGO SELUMETINIB SULFATE CAPSULE; ORAL 25MG Yes No 002 KOSELUGO SELUMETINIB SULFATE CAPSULE; ORAL 10MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213756-001 KOSELUGO SELUMETINIB SULFATE EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 N213756-002 KOSELUGO SELUMETINIB SULFATE EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213756-001 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 N213756-001 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 N213756-001 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 N213756-001 7425637 2028-03-13 Drug substance 2020-05-06 N213756-001 11813246 2029-03-26 Drug product 2023-12-07 N213756-001 12220403 2029-03-26 Drug product 2025-02-14 N213756-001 12318367 2029-03-26 Drug product 2025-07-01 N213756-001 12364684 2029-03-26 U-4357 2025-08-19 N213756-002 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 N213756-002 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 N213756-002 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 N213756-002 7425637 2028-03-13 Drug substance 2020-05-06 N213756-002 11813246 2029-03-26 Drug product 2023-12-07 N213756-002 12220403 2029-03-26 Drug product 2025-02-14 N213756-002 12318367 2029-03-26 Drug product 2025-07-01 N213756-002 12364684 2029-03-26 U-4357 2025-08-19
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 76 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213756-001 KOSELUGO EQ 10MG BASE CAPSULE / ORAL RLD 2020-04-10 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N213756-002 KOSELUGO EQ 25MG BASE CAPSULE / ORAL RLD, RS 2020-04-10 782e0a99824c…
Observed Orange Book patent history# Patent history page 1 of 10 · 370 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N213756-001 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 7425637 2028-03-13 Drug substance 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 11813246 2029-03-26 Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 12220403 2029-03-26 Drug product 2025-02-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 12318367 2029-03-26 Drug product 2025-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-001 12364684 2029-03-26 U-4357 2025-08-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 7425637 2028-03-13 Drug substance 2020-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 11813246 2029-03-26 Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 12220403 2029-03-26 Drug product 2025-02-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 12318367 2029-03-26 Drug product 2025-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213756-002 12364684 2029-03-26 U-4357 2025-08-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213756-001 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 7425637 2028-03-13 Drug substance 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 11813246 2029-03-26 Drug product 2023-12-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 12220403 2029-03-26 Drug product 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 12318367 2029-03-26 Drug product 2025-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-001 12364684 2029-03-26 U-4357 2025-08-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 9562017 2026-12-12 U-4357 Drug substance 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 7425637 2028-03-13 Drug substance 2020-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 11813246 2029-03-26 Drug product 2023-12-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 12220403 2029-03-26 Drug product 2025-02-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 12318367 2029-03-26 Drug product 2025-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213756-002 12364684 2029-03-26 U-4357 2025-08-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 7425637 2026-03-13 Drug substance 2020-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 8178693 2026-03-13 Drug substance, Drug product 2020-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 9156795 2026-12-12 Drug substance, Drug product 2020-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 9562017 2026-12-12 U-4274 Drug substance 2020-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 11813246 2029-03-26 Drug product 2023-12-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 12220403 2029-03-26 Drug product 2025-02-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 12318367 2029-03-26 Drug product 2025-07-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213756-001 12364684 2029-03-26 U-4274 2025-08-19 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 5 · 164 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0310-0610 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0610 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0610 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0610 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0625 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0625 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0625 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current 0310-0625 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 84242 SUPPL 2025-11-21 84234 SUPPL 2025-11-20 83366 SUPPL 2025-09-17 83365 SUPPL 2025-09-17 77298 SUPPL 2024-01-25 77292 SUPPL 2024-01-25 69750 SUPPL 2021-12-23 69749 SUPPL 2021-12-23 62883 ORIG 2020-05-11 62549 ORIG 2020-04-13 62540 ORIG 2020-04-10